Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Personalized and Regenerative Wound Care Adopting Innovative Technologies to Meet Industry Challenges

Frost & Sullivan
Posted on: 15 Aug 17

PR Newswire

SANTA CLARA, California, Aug. 15, 2017

3D printing, information and communication technology, stem cells and sensor technologies best poised to tap growth opportunities in the industry, finds Frost & Sullivan's TechVision team

SANTA CLARA, California, Aug. 15, 2017 /PRNewswire/ -- The aging baby boomer population and rise in the incidence of chronic diseases has intensified focus on innovations in wound care for this difficult-to-heal patient population. Wound care developers are particularly keen on providing advanced and personalized wound repair, and remote wound monitoring and assessment by integrating advanced sensors, information/communication technologies, 3D printing, and stem cell technology with traditional wound healing products. By facilitating documentation and management, digital technologies aid in the standardization of wound care.

"Technology convergence in the healthcare industry is indicative of a positive shift toward greater regenerative, personalized and standardized wound care," noted Frost & Sullivan TechVision Senior Research Analyst Debarati Sengupta. "As the industry moves toward patient-centric care, there is greater focus on bioactive personalized wound care products using stem cell technologies. These emerging wound care technologies are creating highly disruptive growth opportunities, such as real-time, point-of-care wound diagnostics, smart bandages, and personalized wound care treatment. The new breed of wound care solutions aims to achieve superior collaboration among patients, caregivers and clinicians to provide optimal care."

Emerging Woundcare Technologies is part of Frost & Sullivan's TechVision (Health & Wellness) Growth Partnership Service program. This research service focuses on the new and innovative participants in the wound care industry that are introducing disruptive and emerging technologies. It presents industry best practices, emerging growth opportunities, and strategic recommendations for the future of the wound care industry.

To access more information on this analysis, please click here.

Most of the United States federal budget in the wound care industry is channeled toward cell-based regenerative wound therapy, while the majority of venture funding is for digital technology-based wound management companies providing remote or telehealth technology.

"Partnerships or collaborations between wound care developers and complementary technology developers, such as a sensor or a mobile platform company, are crucial to establish cross-industry expertise," observed Sengupta. "Creating user-friendly digital wound care technologies and educating the staff regarding the usage and benefits of new wound care solutions will go a long way in accelerating the adoption of these technologies."

About TechVision

Frost & Sullivan's global TechVision practice is focused on innovation, disruption and convergence and provides a variety of technology-based alerts, newsletters and research services as well as growth consulting services. Its premier offering, the TechVision program, identifies and evaluates the most valuable emerging and disruptive technologies enabling products with near-term potential. A unique feature of the TechVision program is an annual selection of 50 technologies that can generate convergence scenarios, possibly disrupt the innovation landscape, and drive transformational growth. View a summary of our TechVision program by clicking on the following link: http://ifrost.frost.com/TechVision_Demo.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion

Emerging Woundcare Technologies
D7AF

Contact:
Mariana Fernandez
Corporate Communications – North America
P: +1 (210) 348 1012
E: Mariana.Fernandez@frost.com

Twitter: @TechVision_FS
Linkedin: http://www.frost.com/techvisionlinkedin

http://www.frost.com
http://www.frost.com/techvision

PR Newswire
www.prnewswire.com

Last updated on: 15/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.